American International Group Inc. Sells 3,231 Shares of LivaNova PLC (NASDAQ:LIVN)

American International Group Inc. trimmed its holdings in shares of LivaNova PLC (NASDAQ:LIVN) by 3.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 99,313 shares of the company’s stock after selling 3,231 shares during the quarter. American International Group Inc. owned about 0.18% of LivaNova worth $5,138,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Primecap Management Co. CA grew its holdings in shares of LivaNova by 7.3% during the 3rd quarter. Primecap Management Co. CA now owns 5,785,360 shares of the company’s stock valued at $305,930,000 after purchasing an additional 395,940 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of LivaNova by 6.0% during the 3rd quarter. Vanguard Group Inc. now owns 1,770,277 shares of the company’s stock valued at $93,612,000 after purchasing an additional 100,133 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of LivaNova by 6.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,241,985 shares of the company’s stock valued at $64,262,000 after purchasing an additional 74,067 shares during the last quarter. Greenlight Capital Inc. grew its holdings in shares of LivaNova by 3.5% during the 4th quarter. Greenlight Capital Inc. now owns 1,229,316 shares of the company’s stock valued at $63,605,000 after purchasing an additional 42,040 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its holdings in shares of LivaNova by 96.1% during the 3rd quarter. Ameriprise Financial Inc. now owns 916,632 shares of the company’s stock valued at $48,471,000 after purchasing an additional 449,136 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Needham & Company LLC reiterated a “buy” rating and set a $72.00 target price on shares of LivaNova in a research report on Thursday, June 6th. Barclays lifted their target price on shares of LivaNova from $57.00 to $61.00 and gave the stock an “equal weight” rating in a research report on Monday, February 26th. Robert W. Baird lifted their target price on shares of LivaNova from $58.00 to $66.00 and gave the stock a “neutral” rating in a research report on Thursday, May 2nd. StockNews.com upgraded shares of LivaNova from a “hold” rating to a “buy” rating in a research report on Thursday, April 25th. Finally, Mizuho boosted their price target on shares of LivaNova from $75.00 to $80.00 and gave the stock a “buy” rating in a research report on Thursday, May 2nd. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, LivaNova presently has a consensus rating of “Moderate Buy” and a consensus target price of $66.20.

LivaNova Stock Up 1.0 %

Shares of NASDAQ LIVN opened at $56.16 on Friday. The company has a market capitalization of $3.04 billion, a P/E ratio of -93.60 and a beta of 0.99. LivaNova PLC has a 52-week low of $42.75 and a 52-week high of $64.47. The company has a debt-to-equity ratio of 0.50, a quick ratio of 2.71 and a current ratio of 3.17. The company’s 50 day moving average price is $57.75 and its 200-day moving average price is $53.88.

LivaNova (NASDAQ:LIVN) last released its quarterly earnings data on Wednesday, May 1st. The company reported $0.73 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.28. The company had revenue of $294.90 million during the quarter, compared to analyst estimates of $278.17 million. LivaNova had a negative net margin of 2.68% and a positive return on equity of 13.59%. LivaNova’s revenue for the quarter was up 12.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.43 EPS. Equities analysts forecast that LivaNova PLC will post 2.59 earnings per share for the current year.

Insider Activity

In other news, Director Daniel Jeffrey Moore sold 56,623 shares of LivaNova stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $60.11, for a total value of $3,403,608.53. Following the completion of the sale, the director now owns 27,534 shares in the company, valued at approximately $1,655,068.74. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.27% of the stock is currently owned by company insiders.

LivaNova Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.